Prior Medications and the Cardiovascular Benefits From Combination Angiotensin‐Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High‐Risk Hypertensive Patients

BACKGROUND: The ACCOMPLISH (Avoiding Cardiovascular Events Through Combination Therapy in Patients Living with Systolic Hypertension) trial demonstrated that combination therapy using amlodipine, rather than hydrochlorothiazide, in conjunction with benazepril provided greater cardiovascular risk red...

Descripción completa

Detalles Bibliográficos
Autores principales: Brook, Robert D., Kaciroti, Niko, Bakris, George, Dahlöf, Björn, Pitt, Bertram, Velazquez, Eric, Weber, Michael, Zappe, Dion H., Hau, Tsushung, Jamerson, Kenneth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778960/
https://www.ncbi.nlm.nih.gov/pubmed/29301757
http://dx.doi.org/10.1161/JAHA.117.006940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778960/
https://www.ncbi.nlm.nih.gov/pubmed/29301757
http://dx.doi.org/10.1161/JAHA.117.006940

Ejemplares similares